Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Medical Technology
  • FDA clears Johnson & Johnson’s surgical robot for ‘the next era in surgery’

FDA clears Johnson & Johnson’s surgical robot for ‘the next era in surgery’

July 23, 2026Posted inMedical Technology

The FDA has authorized Johnson & Johnson’s Ottava Robotic Surgical System as the company looks to compete with Intuitive Surgical and Medtronic.

Post navigation

Previous Post
transmissible-cancer-discovered-in-freshwater-fish Transmissible Cancer Discovered in Freshwater Fish
Next Post
Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapies

Recent Posts

  • Oral Antiviral Blocks Measles-Like Virus Transmission in Ferrets
  • Sanofi abandons plan to seek approval for eczema drug from $1.1B Kymab buyout
  • Single-Cell Atlas Simultaneously Maps 3D Genome Architecture and DNA Methylation
  • Scribe records upsized $129M IPO to bankroll lipid-lowering genetic meds
  • Single-Cell Maps Reveal Genome Reorganization in Alzheimer’s Brain Cells

Archives

  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top